Singapore markets closed
Straits Times Index
3,297.55 -26.98 (-0.81%) Nikkei
38,814.56 +94.09 (+0.24%) Hang Seng
17,941.78 -170.85 (-0.94%) FTSE 100
8,146.86 -16.81 (-0.21%) Bitcoin USD
66,197.99 -150.72 (-0.23%) CMC Crypto 200
1,375.07 -42.81 (-3.02%)
Aurobindo Pharma Limited (AUROPHARMA.BO)
BSE - BSE Real-time price. Currency in INR
Add to watchlist
At close: 03:29PM IST
Currency in INR
Valuation measures4
| Market cap (intra-day) | 736.73B |
| Enterprise value | 737.28B |
| Trailing P/E | 23.25 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.57 |
| Price/book (mrq) | 2.47 |
| Enterprise value/revenue | 2.57 |
| Enterprise value/EBITDA | 11.91 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.51 |
| 52-week change 3 | 85.85% |
| S&P500 52-week change 3 | 23.76% |
| 52-week high 3 | 1,292.15 |
| 52-week low 3 | 665.65 |
| 50-day moving average 3 | 1,168.62 |
| 200-day moving average 3 | 1,035.23 |
Share statistics
| Avg vol (3-month) 3 | 50.5k |
| Avg vol (10-day) 3 | 39.04k |
| Shares outstanding 5 | 585.17M |
| Implied shares outstanding 6 | 586.33M |
| Float 8 | 280.83M |
| % held by insiders 1 | 52.03% |
| % held by institutions 1 | 32.64% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 4.5 |
| Forward annual dividend yield 4 | 0.36% |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 0.69 |
| Payout ratio 4 | 8.31% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 20 Feb 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 20 Jul 2015 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2024 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 10.94% |
| Operating margin (ttm) | 17.58% |
Management effectiveness
| Return on assets (ttm) | 6.36% |
| Return on equity (ttm) | 11.18% |
Income statement
| Revenue (ttm) | 290.02B |
| Revenue per share (ttm) | 495.04 |
| Quarterly revenue growth (yoy) | 17.10% |
| Gross profit (ttm) | N/A |
| EBITDA | 58.43B |
| Net income avi to common (ttm) | 31.73B |
| Diluted EPS (ttm) | 54.15 |
| Quarterly earnings growth (yoy) | 79.50% |
Balance sheet
| Total cash (mrq) | 63.29B |
| Total cash per share (mrq) | 108.02 |
| Total debt (mrq) | 66.48B |
| Total debt/equity (mrq) | 22.27% |
| Current ratio (mrq) | 1.98 |
| Book value per share (mrq) | 509.34 |
Cash flow statement
| Operating cash flow (ttm) | 24.35B |
| Levered free cash flow (ttm) | -12.93B |
© 2024 Yahoo. All rights reserved.